Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-1910-5p


Loading... Please wait, this might take a few seconds...



Filters
Interactions: 474, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
KIF3B hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr20:32309954-32309972 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RNMT hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr18:13763286-13763306 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TSC22D1 hsa-miR-1910-5p low: 0 high: 1 1 1 1 0.550
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr13:44433937-44433951 HITS-CLIP POSITIVE DIRECT TarBase 7.0
BFAR hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr16:14664945-14664964 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MAZ hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr16:29806852-29806874 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MTFMT hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr15:65026968-65026982 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RPAP1 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr15:41520883-41520910 HITS-CLIP POSITIVE DIRECT TarBase 7.0
BMF hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr15:40089037-40089063 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TRPS1 hsa-miR-1910-5p low: 0 high: 1 1 1 1 0.754
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr8:115619309-115619330 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PPP2CB hsa-miR-1910-5p low: 0 high: 1 1 1 1 0.466
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr8:30785969-30785993 HITS-CLIP POSITIVE DIRECT TarBase 7.0
GYS1 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland BT474 N/A N/A
Location Method Result Regulation Validation Type Source
chr19:48993067-48993079 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NFKBIB hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr19:38905481-38905504 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CLPTM1 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr19:44974509-44974537 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NOVA2 hsa-miR-1910-5p low: 0 high: 1 1 1 1 0.549
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr19:45935685-45935710 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ILVBL hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr19:15115206-15115230 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SLC1A5 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr19:46776980-46776995 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MEGF8 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr19:42350212-42350236 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CYTH2 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr19:48475347-48475367 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TNPO2 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr19:12722218-12722238 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TMEM147 hsa-miR-1910-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr19:35547132-35547151 HITS-CLIP POSITIVE DIRECT TarBase 7.0